# Distalmotion

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/distalmotion

- Industry: Medical Devices & Equipment
- Headquarters: Epalinges, Switzerland
- Website: www.distalmotion.com/
- Total disclosed funding: $460M
- Latest round: Debt (Oct 23, 2026)
- Investors on record: 5

## About

Based in Switzerland, Distalmotion SA specializes in advanced robotic surgical systems, offering innovative solutions that enhance surgical precision and integrate seamlessly into existing healthcare workflows.Founded in 2012 in Épalinges, Switzerland, Distalmotion SA focuses on developing robotic surgery systems. The company has successfully attracted investment through multiple rounds, with the latest being a SERIES G round where it raised USD 150.000 mn led by Revival Healthcare Capital. The company demonstrates a steady growth trajectory under the leadership of CEO Greg Roche. Distalmotion’s core offering is the DEXTER robotic surgery system, designed to facilitate robotic surgical procedures while seamlessly integrating into existing medical workflows. Launched in 2012, DEXTER is engineered for compatibility with various technologies, aiming to enhance surgeons’ capabilities in healthcare settings. It particularly targets outpatient facilities, enabling robotic surgery programs without disrupting standard operations, thereby advancing minimally invasive care. DEXTER serves multiple clients, including hospitals and surgical centers, and caters to a global market focusing on Europe, North America, and Asia.Distalmotion generates revenue through direct sales of the DEXTER robotic surgery system to healthcare institutions and may also utilize subscription models for ongoing support and maintenance services. The business operates on a B2B basis, where hospitals and surgical centers purchase DEXTER, involving combinations of upfront costs and recurring fees for software updates and technical support. Partnerships with healthcare providers may include tailored training programs for surgical teams to effectively utilize DEXTER, reflecting the value of advanced robotic surgical capabilities.Distalmotion SA is focused on expanding its product offerings and market reach. The company is in the process of designing new products to enhance surgical capabilities, with plans to launch these innovations in the coming years. Future growth will also focus on expanding into emerging markets across Latin America and Asia by 2025.

## Funding rounds

- Debt, Oct 23, 2026, $70M — Perceptive
- Series G, Nov 17, 2025, $150M — Revival Healthcare Capital
- Series F, Apr 19, 2023, $150M — Revival Healthcare Capital
- Series E, Jan 18, 2022, $90M — 415 CAPITAL, Revival Healthcare Capital
- Series A, Aug 21, 2013 — Blue Ocean Ventures, Zuhlke Ventures

## Investors

- Blue Ocean Ventures (https://capitalatlas.ai/funds/blue-ocean-ventures) — Series A
- Zuhlke Ventures (https://capitalatlas.ai/funds/zuhlke-ventures) — Series A
- 415 CAPITAL (https://capitalatlas.ai/funds/415-capital) — Series E
- Revival Healthcare Capital (https://capitalatlas.ai/funds/revival-healthcare-capital) — Series E, Series F, Series G
- Perceptive — Debt